Analyst Ratings for AstraZeneca PLC ADR (AZN)Updated: 2017-07-26
An average rating of Overweight has been given to AstraZeneca PLC ADR (NYSE:AZN) by analysts covering the stock. A consensus rating of Overweight was previously issued for AZN last month.
18 analysts declared AZN a buy, 2 gave an overweight rating, 14 gave a hold rating, 1 gave an underweight rating, and 4 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 2. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for AZN. The most optimistic analyst gave a price target of 51.55, implying potential capital gains of 52.74 percent. The most pessimistic price target was 25, implying potential capital losses of -25.93 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Analysts have revised their earnings estimates downwards for this quarter, by about -5.73 percent on average, compared to last month. That number becomes -4.6 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.54 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.1 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 2 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 3 analysts made negative revisions to their fiscal year's estimates.
The growth rate of AZN's earnings is estimated by analysts to be 50.63 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of AZN is 0.55.
AZN has a 52-week high of 35.60 and a 52-week low of 25.55. Currently the stock is 32.09 percent higher than its low, and below the high by 5.2 percent. AZN has a P/E ratio of 27.61. Investors typically compare the P/E ratio to a company's peers in the industry. The AZN value stock report compares AZN to some of its peers using value stock charts. The stock has a market capitalization of $84.02 billion. AZN's next earnings release will be on 0000-00-00, which is days away.